Inclusion of telmisartan in mesocellular foam nanoparticles: Drug loading and release property

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 1, 2010, Pages 17-23

  Zhang, Yanzhuo ^a   Jiang, Tongying ^a   Zhang, Qiang ^b   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Drug delivery system; Drug loading; Enhanced dissolution; Mesocellular foam; Telmisartan; Water insoluble drugs

Indexed keywords

CETRIMIDE; NANOPARTICLE; NITROGEN; POLYMER; TELMISARTAN;

ADSORPTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVAPORATION; FOAM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RADIATION SCATTERING; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 77955652842     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.05.010     Document Type: Article

References (37)

1. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv. Drug Deliv. Rev. 2001, 46:3-26.
2. Lipinski C.A. Poor aqueous solubility - an industry wide problem in drug discovery. Am. Pharm. Rev. 2002, 5:82-85.
3. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 2007, 12:1068-1075.
4. Kesisoglou F., Panmai S., Wu Y. Nanosizing - oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 2007, 59:631-644.
5. Sachs-Barrable K., Lee S.D., Wasan E.K., Thornton S.J., Wasan K.M. Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections. Adv. Drug Deliv. Rev. 2008, 60:692-701.
6. Wong S.M., Kellaway I.W., Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int. J. Pharm. 2006, 317:61-68.
7. Gursoy R.N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drug. Biomed. Pharmacother. 2004, 58:173-182.
8. Barbé C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M. Silica particles: a novel drug-delivery system. Adv. Mater. 2004, 16:1949-1966.
9. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 2007, 46:7548-7558.
10. Wang S. Ordered mesoporous materials for drug delivery. Micropor. Mesopor. Mater. 2009, 117:1-9.
11. Kilpeläinen M., Riikonen J., Vlasova M.A., Huotari A., Lehto V.P., Salonen J., Herzig K.H., Järvinen K. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. J. Control. Release 2009, 137:166-170.
12. Park J.H., Gu L., Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature Mater. 2009, 8:331-336.
13. Chen J.F., Ding H.M., Wang J.X., Shao L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 2004, 25:723-727.
14. Charnay C., Bégu S., Tourné-Péteilh C., Nicole L., Lerner D.A., Devoisselle J.M. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 2004, 57:533-540.
15. Yang P.P., Quan Z.W., Lu L.L., Huang S.S., Lin J. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials 2008, 29:692-702.
16. He Q.J., Zhang J.M., Shi J.L., Zhu Z.Y., Zhang L.X., Bu W.B., Guo L.M., Chen Y. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.
17. Torney F., Trewyn B.G., Lin V.S.Y., Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2007, 2:295-300.
18. Zhao D.Y., Feng J.L., Huo Q.S., Melosh N., Fredrickson G.H., Chmelka B.F., Stucky G.D. Triblock copolymer syntheses of mesoporous silica with periodic 50-300 angstrom pores. Science 1998, 279:548-552.
19. Kresge C.T., Leonowicz M.E., Roth W.J., Vartuli J.C., Beck J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359:710-712.
20. Cao L., Man T., Kruk M. Synthesis of ultra-large-pore SBA-15 silica with two-dimensional hexagonal structure using triisopropylbenzene as micelle expander. Chem. Mater. 2009, 21:1144-1153.
21. Lee C.H., Lin T.S., Mou C.Y. Mesoporous materials for encapsulating enzymes. Nano Today 2009, 4:165-179.
22. Mellaerts R., Mols R., Jammaer J.A.G., Aerts C.A., Annaert P., Humbeeck J.V., Mooter G.V., Augustijns P., Martens J.A. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur. J. Pharm. Biopharm. 2008, 69:223-230.
23. Salonen J., Laitinen L., Kaukonen A.M., Tuura J., Björkqvist M., Heikkilä T., Vähä-Heikkilä K., Hirvonen J., Lehto V.-P. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release 2005, 108:362-374.
24. Yu H., Zhai Q.Z. Mesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipine. Micropor. Mesopor. Mater. 2009, 123:298-305.
25. Heikkilä T., Salonen J., Tuura J., Hamdy M.S., Mul G., Kumar N., Salmi T., Murzin D.Y., Laitinen L., Kaukonen A.M., Hirvonen J., Lehto V.P. Mesoporous silica material TUD-1 as a drug delivery system. Int. J. Pharm. 2007, 331:133-138.
26. Li Y.J., Zhou G.W., Li C.J., Qin D.W., Qiao W.T., Chu B. Adsorption and catalytic activity of Porcine pancreatic lipase on rod-like SBA-15 mesoporous material. Colloids Surf. A 2009, 341:79-85.
27. Thomas M.J.K., Slipper I., Walunj A., Jain A., Favretto M.E., Kallinteri P., Douroumis D. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int. J. Pharm. 2009, 387:272-277.
28. Munoz B., Ramila A., Pérez-Pariente J., Diaz I., Vallet-Regi M. MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 2003, 15:500-503.
29. Song S.W., Hidajat K., Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 2005, 21:9568-9575.
30. Doadrio J.C., Sousa E.M.B., Izquierdo-Barba I., Doadrio A.L., Pérez-Pariente J., Vallet-Regi M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J. Mater. Chem. 2006, 16:462-466.
31. Mal N.K., Fujiwara M., Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 2003, 421:350-353.
32. Trewyn B.G., Slowing I.I., Giri S., Chen H.T., Lin V.S.Y. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc. Chem. Res. 2007, 40:846-853.
33. Horcajada P., Rámila A., Pérez-Pariente J., Vallet-Regi M. Influence of pore size of MCM-41 matrices on drug delivery rate. Micropor. Mesopor. Mater. 2004, 68:105-109.
34. Katiyar A., Yadav S., Smirniotis P.G., Pinto N.G. Synthesis of ordered large pore SBA-15 spherical particles for adsorption of biomolecules. J. Chromatogr. A 2006, 1122:13-20.
35. Schmidt-Winkel P., Lukens W.W., Zhao D., Yang P., Chmelka B.F., Stucky G.D. Mesocellular siliceous foams with uniformly sized cells and windows. J. Am. Chem. Soc. 1999, 121:254-255.
36. Lettow J.S., Han Y.J., Schmidt-Winkel P., Yang P., Zhao D., Stucky G.D., Ying J.Y. Hexagonal to mesocellular foam phase transition in polymer-templated mesoporous silicas. Langmuir 2000, 16:8291-8295.
37. Tran P.H.L., Tran H.T.T., Lee B.J. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J. Control. Release 2008, 129:59-65.